The retained placenta
- PMID: 18793876
- DOI: 10.1016/j.bpobgyn.2008.07.005
The retained placenta
Abstract
The incidence and importance of retained placenta (RP) varies greatly around the world. In less developed countries, it affects about 0.1% of deliveries but has up to 10% case fatality rate. In more developed countries, it is more common (about 3% of vaginal deliveries) but very rarely associated with mortality. There are three main types of retained placenta following the vagina delivery: placenta adherens (when there is failed contraction of the myometrium behind the placenta), trapped placenta (a detached placenta trapped behind a closed cervix) and partial accreta (when there is a small area of accreta preventing detachment). All can be treated by manual removal of placenta, which should be carried out at 30-60 minutes postpartum. Medical management is also an option for placenta adherens and trapped placenta. The need for manual removal can be reduced by 20% by the use of intraumbilical oxytocin (30 i.u. in 30 mL saline). A trapped placenta may respond to glyceryl trinitrate (500 mcg sublingually) or gentle, persistent, controlled cord traction.
Similar articles
-
Sublingual nitroglycerin seems to be effective in the management of retained placenta.Acta Obstet Gynecol Scand. 2008;87(2):222-5. doi: 10.1080/00016340701855654. Acta Obstet Gynecol Scand. 2008. PMID: 18231892 Clinical Trial.
-
Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.Acta Obstet Gynecol Scand. 2007;86(1):48-54. doi: 10.1080/00016340601088570. Acta Obstet Gynecol Scand. 2007. PMID: 17230289 Clinical Trial.
-
The effects of sequential use of oxytocin and sublingual nitroglycerin in the cases of retained placenta.J Matern Fetal Neonatal Med. 2016 Oct;29(20):3254-9. doi: 10.3109/14767058.2015.1124264. Epub 2015 Dec 23. J Matern Fetal Neonatal Med. 2016. PMID: 26701364 Clinical Trial.
-
Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.Eur J Obstet Gynecol Reprod Biol. 1996 Jan;64(1):59-61. doi: 10.1016/0301-2115(95)02273-2. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8801151 Review.
-
The retained placenta.Afr Health Sci. 2001 Aug;1(1):36-41. Afr Health Sci. 2001. PMID: 12789132 Free PMC article. Review.
Cited by
-
Retained placenta and postpartum hemorrhage: time is not everything.Arch Gynecol Obstet. 2021 Oct;304(4):903-911. doi: 10.1007/s00404-021-06027-5. Epub 2021 Mar 20. Arch Gynecol Obstet. 2021. PMID: 33743043 Free PMC article.
-
Umbilical vein injection for management of retained placenta.Cochrane Database Syst Rev. 2021 Mar 11;3(3):CD001337. doi: 10.1002/14651858.CD001337.pub3. Cochrane Database Syst Rev. 2021. PMID: 33705565 Free PMC article.
-
Labor therapeutics and BMI as risk factors for postpartum preeclampsia: A case-control study.Pregnancy Hypertens. 2017 Oct;10:177-181. doi: 10.1016/j.preghy.2017.07.142. Epub 2017 Jul 24. Pregnancy Hypertens. 2017. PMID: 29153674 Free PMC article.
-
Unexpected Dramatic Evolution of Placenta Increta: Case Report and Literature Review.J Pers Med. 2023 Oct 31;13(11):1563. doi: 10.3390/jpm13111563. J Pers Med. 2023. PMID: 38003877 Free PMC article.
-
Racial and ethnic disparities in the incidence, healthcare utilization, and outcomes of retained placenta among delivery hospitalizations in the United States, 2016-2019.BMC Pregnancy Childbirth. 2023 Nov 11;23(1):783. doi: 10.1186/s12884-023-06097-0. BMC Pregnancy Childbirth. 2023. PMID: 37951873 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical